Use this nondisclosure agreement tool to quickly and simply create a template for your company.
Search Results For
Use this nondisclosure agreement tool to quickly and simply create a template for your company.
Use this employee confidential information and invention assignment agreement tool to quickly...
Use this advisor agreement tool to quickly and simply create templates for your company.
Use this consultant confidential information and invention assignment agreement tool to quickly...
Use this employee offer letter tool to quickly and simply create templates for your company.
Use this mutual nondisclosure agreement (NDA) toolkit to quickly and simply create a template...
Our HIPAA Applicability tool can help you determine whether HIPAA's privacy requirements apply to your company in less than 10 minutes.
Orrick's Patent Readiness tool can help determine whether your invention ideas are ready for development into a patent portfolio.
We built our Life Sciences License Readiness Tool to evaluate key considerations innovators will face before entering into a collaboration agreement.
In this report series, we explore trends in venture investing across the life sciences sector, featuring data provided by PitchBook.
Conversations with founders, investors and other key players in tech about creating a more inclusive tech ecosystem.
Leveraging Alternative Financing
This edition of Orrick’s life sciences publication series reviews key trends of venture investment in the life sciences industry during Q1 2023.
On February 10, 2025, a Washington state resident filed a lawsuit against Amazon under the Washington My Health My Data Act.
How the right level of IP due diligence can help inform investment decisions in the life sciences arena.
Healthtech Horizons: Navigating Regulation, Investment, and Strategy in a Transforming Market
Navigating ARPA-H
Stephen Thau and David Sharrow discuss key considerations and common terms for licensing technology from universities to start companies, including communication with technology licensing offices, cost implications, royalty structures, due
A Conversation on Leveraging Spinouts to Preserve and Create Value During Financing Rounds, M&A and IPO Planning